TY - JOUR
KW - Drug Abuse And Alcoholism
KW - opioid use disorder
KW - office-based opioid treatment (OBOT)
KW - Quality Improvement
KW - COVID-19
KW - patient education
KW - Social systems
KW - Health services
KW - patients
KW - craving
KW - Opioids
KW - Sobriety
KW - Telecommunications
KW - buprenorphine
KW - Prescribed
KW - Opiates
KW - access
KW - Socioeconomic Factors
KW - narcotics
KW - Support networks
KW - Substance abuse disorders
KW - Drugs
KW - Pandemics
KW - Medicine
KW - Health Education
KW - Coronaviruses
KW - Telemedicine
KW - Medical technology
KW - underserved populations
KW - Toxicology
AU - Fatima Rahman
AU - NaKiera Evans
AU - Jean Bernhardt
A1 - 
AD - University of Kansas School of Medicine-Wichita, Wichita, Kansas ; Morehouse School of Medicine, Atlanta, USA ; Massachusetts General Hospital, Boston, USA ; University of Kansas School of Medicine-Wichita, Wichita, Kansas
BT - Substance use & misuse
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 7
CY - Philadelphia
DO - 10.1080/10826084.2021.1901935
IS - 7
JF - Substance use & misuse
LA - English
M1 - Journal Article
PB - Taylor & Francis Ltd
PP - Philadelphia
PY - 2021
SN - 10826084
SP - 1005
EP - 1009
EP - 
T1 - Access to OUD Treatment and Maintenance of Sobriety amid the COVID-19 Pandemic
T2 - Substance use & misuse
TI - Access to OUD Treatment and Maintenance of Sobriety amid the COVID-19 Pandemic
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1080/10826084.2021.1901935
VL - 56
VO - 10826084
Y1 - 2021
ER -